ANGIOSARCOMA METASTATIC
Clinical trials for ANGIOSARCOMA METASTATIC explained in plain language.
Never miss a new study
Get alerted when new ANGIOSARCOMA METASTATIC trials appear
Sign up with your email to follow new studies for ANGIOSARCOMA METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare skin cancer: drug combo trial launches
Disease control Recruiting nowThis phase 2 trial is testing a combination of two drugs, pembrolizumab and lenvatinib, in 38 people with a rare and aggressive skin cancer called cutaneous angiosarcoma that cannot be removed by surgery. The goal is to see if this treatment can shrink tumors and improve outcomes…
Matched conditions: ANGIOSARCOMA METASTATIC
Phase: PHASE2 • Sponsor: National Cancer Center, Japan • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New drug cocktail targets rare, aggressive cancer
Disease control Recruiting nowThis phase 2 trial is testing whether combining two chemotherapy drugs—Abraxane and liposomal doxorubicin—can shrink tumors in people with advanced or unresectable angiosarcoma, a rare and aggressive cancer of blood vessels. The study will enroll 69 patients who have already trie…
Matched conditions: ANGIOSARCOMA METASTATIC
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC